An in-frame complex germline mutation in the juxtamembrane intracellular domain causing RET activation in familial

Daniela Cordella1, Marina Muzza, Luisella Alberti

  • 1Istituto Auxologico Italiano, 20095 Cusano, Milan, Italy.

Endocrine-Related Cancer
|September 7, 2006
PubMed

Insights

Researchers identified a complex RET gene mutation causing constitutive activation, leading to familial medullary thyroid cancer (FMTC). This discovery highlights the juxtamembrane region

Area of Science:

  • Genetics and Molecular Biology
  • Oncology
  • Endocrinology

Background:

  • Activating RET proto-oncogene mutations are linked to inherited syndromes like multiple endocrine neoplasia (MEN2A/2B) and medullary thyroid cancer (MTC).
  • Most MEN2A and familial MTC (FMTC) cases involve single base pair missense mutations in the extracellular Cys-rich domain of RET.
  • Somatic deletions and germline duplications in RET are rarely observed in sporadic MTC and FMTC.

Observation:

  • A novel deletion/insertion mutation in exon 11 (c.2646delGinsTTCT) was detected in a family with FMTC.
  • This complex rearrangement resulted in an Asn to Lys change (Lys666Asn) and a Ser insertion in the RET protein.
  • The mutation was identified in a metastatic MTC patient and her son, who showed early signs of C-cell hyperplasia.

Findings:

  • The identified RET mutation demonstrated stronger transforming activity than wild-type RET (Ret-WT) in focus formation assays.
  • Functional analyses revealed increased autophosphorylation, indicating constitutive activation of the mutant RET receptor.
  • Computational analysis predicted significant conformational changes in the mutant RET protein, suggesting a novel activation mechanism not dependent on stable dimer formation.

Implications:

  • This study reports the first molecular investigation of a complex germline RET mutation in the receptor's juxtamembrane region.
  • Alterations in this region can lead to ligand-independent RET activation, contributing to FMTC development.
  • Understanding these complex mutations provides insights into MTC pathogenesis and potential therapeutic targets.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Point and Frameshift Mutations01:30

Point and Frameshift Mutations

Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...